Announcement of The Consolidated Financial Report for The 1st Quarter of 2021

2021.5.6

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2021/05/06 Time of announcement 17:50:47
Subject Announcement of The Consolidated Financial Report for The 1st Quarter of 2021
Date of events 2021/05/06 To which item it meets paragraph 31
Statement 1.Date of the financial reports submitted to the board of directors or approved by the board of directors:2021/05/06
2.Date of the financial reports approved by the audit committee:2021/05/06
3.Start and end dates of financial reports of the reporting period:2021/01/01~2021/03/31
4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):964,056
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):611,251
6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):219,162
7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):253,043
8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):201,850
9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):203,144
10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):0.82
11.Total assets end of the period (thousand NTD):9,509,243
12.Total liabilities end of the period (thousand NTD):3,236,123
13.Equity attributable to owners of parent end of the period (thousand NTD):5,626,206
14.Any other matters that need to be specified:None
TOP